179 related articles for article (PubMed ID: 19711726)
21. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
[TBL] [Abstract][Full Text] [Related]
22. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer.
Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980
[TBL] [Abstract][Full Text] [Related]
23. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
[TBL] [Abstract][Full Text] [Related]
24. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte.
Kim BW; Jeon YE; Cho H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
J Obstet Gynaecol Res; 2012 Jan; 38(1):48-56. PubMed ID: 22142582
[TBL] [Abstract][Full Text] [Related]
28. Plasma calprotectin concentrations in women with endometrial carcinoma.
Ni Bhriain H; Trovik J; Wik E; Stefansson IM; Akslen LA; Salvesen HB; Staff AC
Gynecol Oncol; 2009 Sep; 114(3):491-5. PubMed ID: 19577278
[TBL] [Abstract][Full Text] [Related]
29. CA 125: a potential tumor marker for gallbladder cancer.
Chaube A; Tewari M; Singh U; Shukla HS
J Surg Oncol; 2006 Jun; 93(8):665-9. PubMed ID: 16724349
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
[TBL] [Abstract][Full Text] [Related]
31. Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer.
Camlica H; Duranyildiz D; Tas F; Yasasever V
Am J Clin Oncol; 2008 Dec; 31(6):585-8. PubMed ID: 19060592
[TBL] [Abstract][Full Text] [Related]
32. The effect of cadmium on the coagulation and fibrinolytic system in women with uterine endometrial cancer and myoma.
Nasiadek M; Kilanowicz A; Darago A; Lazarenkow A; Michalska M
Int J Occup Med Environ Health; 2013 Apr; 26(2):291-301. PubMed ID: 23690264
[TBL] [Abstract][Full Text] [Related]
33. [Regulation of ceruloplasmin activity in oncogynecological diseases].
Gusarova IuN; Stepanova EV; Landesman EO; Koroleva OV; Vavilova TP; Makarov OV; Kosetskiĭ VN
Vopr Med Khim; 2002; 48(4):388-93. PubMed ID: 12506616
[TBL] [Abstract][Full Text] [Related]
34. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between serum CA125 level and prognosis in the patients with uterine endometrial carcinoma].
Xie Z; Zhang J; Tan A
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1456-7. PubMed ID: 11930622
[TBL] [Abstract][Full Text] [Related]
36. Significance of laboratory studies for ruling out metastases in primary endometrial carcinoma.
Heyer H; Grunwald S; Köhler G; Ohlinger R
Anticancer Res; 2007; 27(3B):1673-7. PubMed ID: 17595795
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic value of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase measurement in the sera of patients with endometrial cancer.
Orywal K; Jelski W; Zdrodowski M; Szmitkowski M
Anticancer Res; 2013 Sep; 33(9):3725-30. PubMed ID: 24023302
[TBL] [Abstract][Full Text] [Related]
38. New molecular tumor markers for endometrial cancer.
Numa F; Umayahara K; Suehiro Y; Suminami Y; Oga A; Sasaki K; Kato H
Hum Cell; 2001 Dec; 14(4):272-4. PubMed ID: 11925928
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of serum CP2, CA125, salicylic acid and carcinoembryonic antigen in endometrial carcinoma].
Wang ZQ; Wang JL; Yang JH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):18-22. PubMed ID: 18366926
[TBL] [Abstract][Full Text] [Related]
40. The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri.
Koshiyama M; Okamoto T; Ueta M
Cancer Detect Prev; 2004; 28(2):94-8. PubMed ID: 15068832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]